← Back

Wire · operational-macro

FDA Introduces New Approach to Drug Quality Sampling and Testing

Published

18 November 2026

Topic

operational-macro

◆ Sectors

Health

◆ Geography

United States

◆ Source

Read at fda.gov →

◆ Verified

Fusion42 · 18 November 2026 · Fusion42 review

The U.S. FDA launched the Enhanced Approach for Sampling and Testing (EAST) initiative to improve drug quality monitoring by combining modern screening techniques with traditional testing, expanding testing scope across manufacturers, therapeutic classes, and geographies. This approach accelerates identification of quality issues and informs regulatory decisions and future inspections.

This Wire brief sits within Fusion42's coverage of Health.

◆ ◆ The Wire takeaway

You now face a higher bar for drug quality monitoring, as FDA broadens testing to catch defects earlier across more products and locations. Speed up quality assurance efforts to align with FDA’s expanded oversight and avoid surprises.

◆ Coverage

1 source · 18 Nov 2026

◆ Related on Wire

◆ Topics

HealthFDAdrug-qualityregulationsampling-testingpublic-health